Account
Motivator India wins media mandate for MilkLane
NEW DELHI: Motivator India has won the media mandate for India's first industrial-scale high-quality milk collection and supply platform, MilkLane. This relationship will start from handling the launch of the brand Nutrinos. Motivator India will manage offline and online media for MilkLane.
MilkLane Dairy Services Private Ltd marketing lead Vivek Sharma said, “Nutrinos is creating a new RTE product category with fortified dairy products with a focus on growth and development of kids. The mandate is interesting and niche – with Motivator’s expertise in developing new brands and their varied portfolio of clients, they align well with our strategic marketing tasks. We have our work cut out for us in establishing the Nutrinos brand in the market as the most loved trusted and loved dairy brand in India.”
Motivator, India MD Mausami Kar said, “We are delighted to partner with MilkLane as they set up to redefine the dairy supply chain, delivering high quality, toxin-free milk at scale to consumers. With Motivator’s expertise and proven track record of working with businesses, especially emerging brands pivoting their trajectory from start-up through scale-up, this promises to be a mutually fulfilling association. We are privileged by this opportunity and look forward to playing our part with gusto, in MilkLane’s brand journey.”
Motivator India chief growth officer Rajiv Khurana said, “Our team is thrilled to partner with MilkLane which is committed to supplying high-quality dairy products, PAN India. In this mutually beneficial partnership, we ensure that with our expertise in scaling up businesses we will create awareness on Nutrinos as a market leader in providing nutrition and good health. Looking forward to this new journey with the MilkLane team.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
